Bulk T-cell receptor sequencing confirms clonality in obstetric antiphospholipid syndrome and may as a potential biomarker

Qi Liua Institute of Medical Technology, Peking University Health Science Center, Beijing, China;b Department of Clinical Laboratory, Peking University Third Hospital, Beijing, China;c Core Unit of National Clinical Research Center for Laboratory Medicine, Peking University Third Hospital, Beijing, ChinaView further author information

Shuo Yangb Department of Clinical Laboratory, Peking University Third Hospital, Beijing, China;c Core Unit of National Clinical Research Center for Laboratory Medicine, Peking University Third Hospital, Beijing, ChinaView further author information

Yuan Tana Institute of Medical Technology, Peking University Health Science Center, Beijing, China;b Department of Clinical Laboratory, Peking University Third Hospital, Beijing, China;c Core Unit of National Clinical Research Center for Laboratory Medicine, Peking University Third Hospital, Beijing, ChinaView further author information

Weimin Fenga Institute of Medical Technology, Peking University Health Science Center, Beijing, China;b Department of Clinical Laboratory, Peking University Third Hospital, Beijing, China;c Core Unit of National Clinical Research Center for Laboratory Medicine, Peking University Third Hospital, Beijing, ChinaView further author information

Qingchen Wangb Department of Clinical Laboratory, Peking University Third Hospital, Beijing, China;c Core Unit of National Clinical Research Center for Laboratory Medicine, Peking University Third Hospital, Beijing, ChinaView further author information

Jiao Qiaoa Institute of Medical Technology, Peking University Health Science Center, Beijing, China;b Department of Clinical Laboratory, Peking University Third Hospital, Beijing, China;c Core Unit of National Clinical Research Center for Laboratory Medicine, Peking University Third Hospital, Beijing, ChinaView further author information

Boxing Yangb Department of Clinical Laboratory, Peking University Third Hospital, Beijing, China;c Core Unit of National Clinical Research Center for Laboratory Medicine, Peking University Third Hospital, Beijing, ChinaView further author information

Chong Wangb Department of Clinical Laboratory, Peking University Third Hospital, Beijing, China;c Core Unit of National Clinical Research Center for Laboratory Medicine, Peking University Third Hospital, Beijing, ChinaView further author information

Jingjin Taoa Institute of Medical Technology, Peking University Health Science Center, Beijing, China;b Department of Clinical Laboratory, Peking University Third Hospital, Beijing, China;c Core Unit of National Clinical Research Center for Laboratory Medicine, Peking University Third Hospital, Beijing, ChinaView further author information

He Wangb Department of Clinical Laboratory, Peking University Third Hospital, Beijing, China;c Core Unit of National Clinical Research Center for Laboratory Medicine, Peking University Third Hospital, Beijing, ChinaView further author information

Liyan Cuia Institute of Medical Technology, Peking University Health Science Center, Beijing, China;b Department of Clinical Laboratory, Peking University Third Hospital, Beijing, China;c Core Unit of National Clinical Research Center for Laboratory Medicine, Peking University Third Hospital, Beijing, ChinaCorrespondence[email protected]
View further author information

show all

Bulk T-cell receptor sequencing confirms clonality in obstetric antiphospholipid syndrome and may as a potential biomarker

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Bulk T-cell receptor sequencing confirms clonality in obstetric antiphospholipid syndrome and may as a potential biomarker

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date